Deficient Mismatch Repair and Microsatellite Instability in Solid Tumors
International Journal of Molecular Sciences · 06.05.2025 · 26 (9) · 4394
DOI: 10.3390/ijms26094394 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 06.05.2025. Verfasst von Joy A Awosika und 2 weiteren Autor:innen. Beteiligte Einrichtung: Gastrointestinal Malignancies Section, Thoracic & GI Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes …. Hauptthemen laut MEDLINE: Microsatellite Instability, DNA Mismatch Repair, Neoplasms. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 163 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The integrity of the genome is maintained by mismatch repair (MMR) proteins that recognize and repair base mismatches and insertion/deletion errors generated during DNA replication and recombination. A defective MMR system results in genome-wide instability and the progressive accumulation of mutations. Tumors exhibiting deficient MMR (dMMR) and/or high levels of microsatellite instability (termed “microsatellite instability high”, or MSI-H) have been shown to possess fundamental differences in clinical, pathological, and molecular characteristics, distinguishing them from their “microsatellite stable” (MSS) counterparts. Molecularly, they are defined by a high mutational burden, genetic instability, and a distinctive immune profile. Their distinct genetic and immunological profiles have made dMMR/MSI-H tumors particularly amenable to treatment with immune checkpoint inhibitors (ICIs). The ongoing development of biomarker-driven therapies and the evaluation of novel combinations of immune-based therapies, with or without the use of conventional cytotoxic treatment regimens, continue to refine treatment strategies with the goals of maximizing therapeutic efficacy and survival outcomes in this distinct patient population. Moreover, the resultant knowledge of the mechanisms by which these features are suspected to render these tumors more responsive, overall, to immunotherapy may provide information regarding the potential optimization of this therapeutic approach in tumors with proficient MMR (pMMR)/MSS tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Gastrointestinal Malignancies Section, Thoracic & GI Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
- Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
ORCID-Profile: Joy A Awosika
Zitieren
APA
Awosika, J. A., Gulley, J. L., & Pastor, D. M. (2025). Deficient Mismatch Repair and Microsatellite Instability in Solid Tumors. International Journal of Molecular Sciences, 26(9), 4394. https://doi.org/10.3390/ijms26094394
Vancouver
Awosika JA, Gulley JL, Pastor DM. Deficient Mismatch Repair and Microsatellite Instability in Solid Tumors. International Journal of Molecular Sciences. 2025;26(9):4394. doi:10.3390/ijms26094394
BibTeX
@article{Awosika2025,
author = {Awosika, Joy A and Gulley, James L and Pastor, Danielle M},
title = {Deficient Mismatch Repair and Microsatellite Instability in Solid Tumors},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {9},
pages = {4394},
doi = {10.3390/ijms26094394}
}
EUVIMED